Cardiac Radioablation for VT
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCorewell Health East
About this trial
The goal of this interventional study is to determine the minimum dose necessary for successful cardiac radioablation of refractory ventricular tachycardia (VT) and to study the utility of target volume definition using Delayed Enhancement Cardiac MRI (DE-CMR) .
Eligibility criteria
Qualifiers
Participants must be 18 years or older.
Automatic implanted cardiac defibrillator present.
VT is monomorphic with at least two episodes of VT within an eight week (56 day) period as recorded by an AICD or heart failure related to VT or VT storm.
Ejection fraction ≥20%.
Disqualifiers
Class IV heart failure
Abandoned leads.
Prior radiation therapy to the chest or upper abdomen.
Interstitial lung disease.
Trial design
Treatments tested in this trial
- Stereotactic Body Radiation Therapy (SBRT)
Treatment groups
24 Participants
are divided into 3 treatment groupsLocations
1Corewell Health William Beaumont University Hospital48073, Royal OakMichigan, United States
Sponsors and collaborators
Corewell Health East
Lead sponsor
Source ClinicalTrials.gov